Virtus ETF Advisers’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-1,363
Closed -$711K – 476
2023
Q2
$711K Sell
1,363
-103
-7% -$55.6K 0.42% 109
2023
Q1
$845K Sell
1,466
-92
-6% -$51.9K 0.46% 83
2022
Q4
$858K Buy
1,558
+377
+32% +$200K 0.45% 41
2022
Q3
$599K Sell
1,181
-116
-9% -$64.9K 0.24% 175
2022
Q2
$705K Buy
+1,297
New +$714K 0.26% 119
2020
Q3
– Sell
-45
Closed -$16K – 419
2020
Q2
$16K Sell
45
-145
-76% -$48.6K 0.01% 399
2020
Q1
$54K Buy
190
+55
+41% +$17.3K 0.02% 299
2019
Q4
$44K Buy
+135
New +$40.9K 0.01% 302

Other funds holding TMO

Virtus ETF Advisers's TMO Position: Q3 2023 in Review

Virtus ETF Advisers sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 1,363 shares — an estimated $711K sold.

Virtus ETF Advisers first reported a position in TMO in Q4 2019 and held it in 8 quarters. The position peaked at $858K in Q4 2022. 2,365 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

  • Virtus ETF Advisers reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
  • Virtus ETF Advisers sold 1,363 Thermo Fisher Scientific shares in Q3 2023, an estimated $711K.
  • Virtus ETF Advisers first reported a position in Thermo Fisher Scientific in Q4 2019 and held it in 8 quarters.
  • Virtus ETF Advisers's Thermo Fisher Scientific position peaked at $858K in Q4 2022.
  • 2,365 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Virtus ETF Advisers's 13F filing for Q3 2023, filed 7 Nov 2023.